Document Detail

Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
MedLine Citation:
PMID:  8606275     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: This study sought to test the hypothesis that big endothelin-1 plasma levels in advanced heart failure are related to survival. BACKGROUND: In heart failure, production of the potent vasoconstrictor endothelin-1 is increased. Because elevation of immunoreactive endothelin-1 in severe heart failure is primarily related to the precursor "big" endothelin-1, increased big endothelin-1 levels may be associated with a poor prognosis. METHODS: Plasma big endothelin-1 concentrations, in addition to 16 clinical, hemodynamic and neurohumoral variables, were obtained from 113 patients (mean age -=/[SEM] 53 +/- 1 years) with left ventricular ejection fraction <20% and were related to 1-year mortality by a stepwise Cox regression multivariate analysis. RESULTS: Plasma big endothelin-1 concentrations were significantly higher in patients with moderate and severe heart failure than in those with mild heart failure (4.5 +/- 0.4 and 6.0 +/- 0.1 vs. 2.7 +/- 0.1 fmol/ml, p = 0.0001, respectively) and lower in 58 one-year survivors than in 29 nonsurvivors (2.6 +/- 0.1 vs. 5.9 +/- .04 fmol/ml, p = 0.0001) and 26 heart transplant recipients. By univariate analysis, big endothelin-1 plasma concentrations (p < 0.0001), functional class, daily furosemide dose, left ventricular ejection fraction, most hemodynamic variables and plasma atrial natriuretic peptide, sodium renin activity and aldosterone levels were all related to mortality, but only functional class provided additional prognostic information when big endothelin-1 plasma levels were entered into the multivariate model. CONCLUSIONS: In advanced heart failure, plasma big endothelin-1 is strongly related to survival and appears to predict 1-year mortality better than hemodynamic variables and levels of atrial natriuretic peptide, an established neurohumoral prognostic marker in chronic heart failure.
R Pacher; B Stanek; M Hülsmann; J Koller-Strametz; R Berger; M Schuller; E Hartter; E Ogris; B Frey; G Heinz; G Maurer
Related Documents :
9804395 - Pattern of plasma cyclic nucleotides and related hormones in liver cirrhosis and hepato...
8379845 - Atrial natriuretic factor in spinal cord injury.
2553325 - Carbidopa does not affect the renal response to atrial natriuretic factor in man.
1837565 - Plasma atrial natriuretic factor in isolated systolic hypertension in the elderly: resp...
16727405 - Evidence that testosterone and follicular fluid do not interact in the control of fsh s...
21352365 - Intact recovery from early "acquired methylmalonic aciduria" secondary to maternal atro...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  27     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1996 Mar 
Date Detail:
Created Date:  1996-05-22     Completed Date:  1996-05-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  633-41     Citation Subset:  AIM; IM    
Department of Cardiology, University of Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Atrial Natriuretic Factor / blood*
Endothelins / blood*
Heart Failure / blood*,  mortality,  physiopathology
Middle Aged
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Protein Precursors / blood*
Severity of Illness Index
Survival Analysis
Reg. No./Substance:
0/Endothelin-1; 0/Endothelins; 0/Protein Precursors; 85637-73-6/Atrial Natriuretic Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from t...
Next Document:  Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline chara...